Silver Book Fact

The annual burden to the U.S. economy of age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma, refractive errors, visual impairment, and blindness in adults age 40 and older is estimated at $35.4 billion– $16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in lost productivity.

Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine. The Economic Burden of Major Adult Visual Disorders in the United States. Archives of Ophthalmology. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Archives of Ophthalmology
Publication Date
2006
Authors
Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Prevalence of Diabetic Retinopathy by Age, in the US
     
  • More than 2.1 million Americans age 80 and older have low vision or are blind– 23.7% of the 80 and older population.  
  • The annual governmental budgetary impact of major adult visual disorders is estimated to be at least $13.7 billion  
  • An estimated 4.1 million Americans age 40 and older have diabetic retinopathy.  
  • More than 1 in 10 Americans over the age of 80 has advanced age-related macular degeneration (AMD)– 1.08 million Americans 80 and older.